/ pharma
/ Market Analysis
BioNTech Seals $1.25B CureVac Deal to Accelerate Cancer Treatment Development
BioNTech's $1.25 billion acquisition of CureVac creates a "German biotech champion" focused on mRNA-based cancer treatments, with CureVac shares surging 38% on ...
June 12, 2025
Eli Lilly’s Stock Soars After Weight-Loss Pill Competing with Ozempic Shows Promise
Eli Lilly's new weight-loss pill, matches Ozempic in effectiveness.
April 17, 2025
Premarket Moves: Nike Dips 11%, Karuna Therapeutics Soars 48%
A quick look at the biggest premarket moves today. NKE dips 11% while KRTX shoots up on a buyout deal.
December 22, 2023
Moderna Shares Jump 12% After Cancer Vaccine Shows Positive Results
Moderna's shares surged by more than 12% in premarket trading on Thursday following encouraging trial data for its skin cancer vaccine.
December 14, 2023
Pfizer’s Stock is Down 44% YTD as Woes Continue
Pfizer's shares plunged on Friday after the drugmaker halted the trial of its twice-daily obesity drug.
December 01, 2023More from The Tokenist / pharma
Back to 
